Cargando…
Digitoxin medication and cancer; case control and internal dose-response studies
BACKGROUND: Digitoxin induces apoptosis in different human malignant cell lines in vitro. In this paper we investigated if patients taking digitoxin for cardiac disease have a different cancer incidence compared to the general population. METHODS: Computer stored data on digitoxin concentrations in...
Autores principales: | Haux, Johan, Klepp, Olbjørn, Spigset, Olav, Tretli, Steinar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC48150/ https://www.ncbi.nlm.nih.gov/pubmed/11532201 http://dx.doi.org/10.1186/1471-2407-1-11 |
Ejemplares similares
-
Digitoxin—A Critical Review
por: Diefenbach, William C., et al.
Publicado: (1949) -
Digitoxin and its analogs as novel cancer therapeutics
por: Elbaz, Hosam A, et al.
Publicado: (2012) -
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
por: Bavendiek, Udo, et al.
Publicado: (2023) -
Accidental digitoxin intoxication: an interplay between laboratory and clinical medicine
por: Castello, Luigi M, et al.
Publicado: (2012) -
Digitoxin activates EGR1 and synergizes with paclitaxel on human breast cancer cells
por: Einbond, Linda Saxe, et al.
Publicado: (2010)